Tumor-derived interleukin-1α and leukemia inhibitory factor promote extramedullary hematopoiesis.
Extramedullary hematopoiesis (EMH) expands hematopoietic capacity outside of the bone marrow in response to inflammatory conditions, including infections and cancer. Because of its inducible nature, EMH offers a unique opportunity to study the interaction between hematopoietic stem and progenitor ce...
Main Authors: | Derek A G Barisas, Ashraf Ul Kabir, Jun Wu, Karen Krchma, Minseo Kim, Madhav Subramanian, Bernd H Zinselmeyer, Colin L Stewart, Kyunghee Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-05-01
|
Series: | PLoS Biology |
Online Access: | https://doi.org/10.1371/journal.pbio.3001746 |
Similar Items
-
Extramedullary hematopoiesis in cancer
by: Derek A. G. Barisas, et al.
Published: (2024-03-01) -
Extramedullary Hematopoiesis of the Liver and Spleen
by: Diana Cenariu, et al.
Published: (2021-12-01) -
Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis
by: Damian T. Rieke, et al.
Published: (2024-01-01) -
Reversible paraparesis due to extramedullary hematopoiesis
by: Eti Muharremi, et al.
Published: (2023-06-01) -
Extramedullary hematopoiesis in murine schistosomiasis mansoni
by: H. L. Lenzi, et al.
Published: (1995-04-01)